Valneva Future Growth

Future criteria checks 5/6

Valneva is forecast to grow earnings and revenue by 4.6% and 24.6% per annum respectively. EPS is expected to grow by 17.6% per annum. Return on equity is forecast to be -27.7% in 3 years.

Key information

4.6%

Earnings growth rate

17.6%

EPS growth rate

Biotechs earnings growth37.1%
Revenue growth rate24.6%
Future return on equity-27.7%
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0OB3 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026285-39-1-48
12/31/2025213-67-57-509
12/31/20241701040447
9/30/2024159-7-169-143N/A
6/30/2024156-32-215-204N/A
3/31/2024153-24-222-207N/A
12/31/2023154-101-217-203N/A
9/30/2023223-113-208-193N/A
6/30/2023426-7-231-211N/A
3/31/2023373-135-267-243N/A
12/31/2022361-143-275-245N/A
9/30/202243973-195-149N/A
6/30/2022304-159-177-108N/A
3/31/2022347-72-832N/A
12/31/2021348-73-1677N/A
9/30/2021121-2481597N/A
6/30/2021110-12551109N/A
3/31/202198-91147182N/A
12/31/2020110-64118138N/A
9/30/2020104-626778N/A
6/30/2020120-2597105N/A
3/31/2020127-8-73N/A
12/31/2019126-2-56N/A
9/30/20191164010N/A
6/30/201910911016N/A
3/31/201911671417N/A
12/31/201811331316N/A
9/30/2018107-746N/A
6/30/2018110-7N/A10N/A
3/31/2018108-8N/A5N/A
12/31/2017105-11N/A13N/A
9/30/2017103-11N/A17N/A
6/30/2017100-14N/A19N/A
3/31/2017102-46N/A25N/A
12/31/201698-49N/A7N/A
9/30/201693-63N/A4N/A
6/30/201696-61N/A-5N/A
3/31/201689-35N/A-17N/A
12/31/201583-21N/A-20N/A
9/30/201574-16N/A-24N/A
6/30/201565-13N/A-19N/A
3/31/201555-9N/A-15N/A
12/31/201442-26N/A-15N/A
9/30/201441-21N/A-6N/A
6/30/201443-28N/A-21N/A
3/31/201441-29N/A-27N/A
12/31/201336-24N/A-21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0OB3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: 0OB3 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 0OB3 is expected to become profitable in the next 3 years.

Revenue vs Market: 0OB3's revenue (24.6% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0OB3's revenue (24.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0OB3 is forecast to be unprofitable in 3 years.


Discover growth companies